Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD8+ Memory T-Cells Post-Transplant for Leukemia and Lymphoma
NCT02424968Phase 2Completed
- Start
- Jun 2015
- Primary completion
- Jul 2020
- Modality
- Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs), TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic cd8+ memory t-cells in acute myeloid leukemia (AML), B-cell non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), Hodgkin lymphoma (HL), myelodysplastic syndrome (MDS). Started Jun 2015; status: completed.
02
Drugs
allogeneic cd8+ memory t-cells
03
Conditions
acute myeloid leukemia (AML)B-cell non-Hodgkin lymphomachronic lymphocytic leukemia (CLL)Hodgkin lymphoma (HL)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT02424968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02424968.